Simultaneous determination of ten antihistamine drugs in human plasma using pipette tip solid-phase extraction and gas chromatography/mass spectrometry.
Chika Hasegawa, Takeshi Kumazawa, Xiao-Pen Lee, Masaya Fujishiro, Ayako Kuriki, Akemi Marumo, Hiroshi Seno, Keizo Sato
Index: Rapid Commun. Mass Spectrom. 20(4) , 537-43, (2006)
Full Text: HTML
Abstract
Ten antihistamine drugs, diphenhydramine, orphenadrine, chlorpheniramine, diphenylpyraline, triprolidine, promethazine, homochlorcyclizine, cyproheptadine, cloperastine and clemastine, have been found to be extractable from human plasma samples using MonoTip C18 tips, inside which C18- bonded monolithic silica gel was fixed. Human plasma (0.1 mL) containing the ten antihistamines was mixed with 0.4 mL of distilled water and 25 microL of a 1 M potassium phosphate buffer (pH 8.0). After centrifugation of the mixture, the supernatant fraction was extracted to the C18 phase of the tip by 25 repeated aspirating/dispensing cycles using a manual micropipettor. The analytes retained on the C18 phase were then eluted with methanol by five repeated aspirating/dispensing cycles. The eluate was injected into a gas chromatography (GC) injector without evaporation and reconstitution steps, and was detected by a mass spectrometer with selected ion monitoring in the positive-ion electron impact mode. The separation of the ten drugs from each other and from impurities was generally satisfactory using a DB-1MS column (30 m x 0.32 mm i.d., film thickness 0.25 microm). The recoveries of the ten antihistamines spiked into plasma were 73.8-105%. The regression equations for the ten antihistamines showed excellent linearity with detection limits of 0.02-5.0 ng/0.1 mL. The within-day and day-to-day coefficients of variation for plasma were not greater than 9.9%. The data obtained from determination of diphenhydramine and chlorpheniramine in human plasma after oral administration of the drugs are also presented.Copyright 2006 John Wiley & Sons, Ltd.
Related Compounds
Related Articles:
A possible approach to the suppression of side effects induced by PGE1.
1995-01-01
[Prostaglandins Leukot. Essent. Fatty Acids 52(1) , 17-20, (1995)]
2012-05-15
[Eur. J. Pharmacol. 683(1-3) , 161-5, (2012)]
Effects of H1 antihistamines on canine nasal vascular and airway resistances.
1987-06-01
[Rhinology 25(2) , 95-100, (1987)]
[Parkinsonism associated with cerebrotendinous xanthomatosis].
1990-09-01
[Rinsho. Shinkeigaku 30(9) , 978-84, (1990)]
2001-01-01
[J. Neurol. Sci. 182(2) , 95-7, (2001)]